Loading clinical trials...
Loading clinical trials...
This is a proof of concept, single center study for the donation of HCV-positive lungs to HCV negative recipient patients, with preemptive, interventional treatment with 8 weeks of commercially availa...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Massachusetts General Hospital
NCT06213168 · De Novo Hypoxemic Acute Respiratory Failure (hARF)
NCT07451977 · Chronic Respiratory Failure, Hypoxemia, and more
NCT06189924 · Acute Respiratory Failure, Critical Illness
NCT06953479 · HEPATITIS C (HCV), Incarceration, and more
NCT07186933 · Postoperative Pulmonary Atelectasis, Postoperative Pulmonary Complications, and more
Massachusetts General Hospital
Boston, Massachusetts
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions